A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer

Clinical trial NCT00862784 · COMPLETED

Trial details

NCT number: NCT00862784
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Carcinoma

Start date: 2009-04-01
Primary completion: 2011-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.